• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刚果民主共和国患者对疟疾治疗依从性的决定因素

Determinants of Patients' Adherence to Malaria Treatment in the Democratic Republic of the Congo.

作者信息

Ntamabyaliro Nsengi Y, Burri Christian, Lula Yves N, Nzolo Didier B, Engo Aline B, Ngale Mireille A, Situakibanza Hippolyte N, Mukomena Eric S, Mesia Gauthier K, Mampunza Samuel M, Tona Gaston L

机构信息

Unité de Pharmacologie Clinique, Faculté de Médecine, Université de Kinshasa, Kinshasa P.O. Box 834, Democratic Republic of the Congo.

Swiss Tropical and Public Health Institute, Kreuzstrasse 2, 4123 Allschwil, Switzerland.

出版信息

Trop Med Infect Dis. 2022 Jul 18;7(7):138. doi: 10.3390/tropicalmed7070138.

DOI:10.3390/tropicalmed7070138
PMID:35878149
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9318296/
Abstract

(1) Background: Malaria heavily affects the Democratic Republic of the Congo (DRC) despite the use of effective drugs. Poor adherence to malaria treatment may contribute to this problem. (2) Methods: In one rural and one urban health area in each of the 11 former provinces of the DRC, all households with a case of malaria in the 15 days preceding the survey were selected and the patients or caregivers were interviewed. Adherence to malaria treatment was assessed by self-declaration about its completion. Logistic regression was used to assess predictors. (3) Results: 1732 households participated. Quinine was the most used drug; adherence to artesunate-amodiaquine was the lowest and the main reason for treatment discontinuation was adverse reactions. Predictors of adherence were residence in an urban area, university education, catholic religion, and adoption of recommended behaviour towards a malaria case. Adherence was significantly lower for responders who obtained information on antimalarials from Community Health Workers (CHW). (4) Conclusions: Usage of recommended drugs and adherence to malaria treatment need to be promoted, especially in rural areas, and CHW involvement needs to be improved. Awareness messages need to be made accessible and comprehensible to poorly educated populations and churches need to be involved.

摘要

(1) 背景:尽管使用了有效药物,但疟疾仍严重影响刚果民主共和国(DRC)。对疟疾治疗的依从性差可能是导致这一问题的原因之一。(2) 方法:在刚果民主共和国11个前省份的每个省份各选取一个农村和一个城市卫生区,选择在调查前15天内有疟疾病例的所有家庭,并对患者或照料者进行访谈。通过自我申报治疗完成情况来评估对疟疾治疗的依从性。采用逻辑回归分析来评估预测因素。(3) 结果:1732户家庭参与。奎宁是使用最多的药物;对青蒿琥酯 - 阿莫地喹的依从性最低,治疗中断的主要原因是不良反应。依从性的预测因素包括居住在城市地区、受过大学教育、信奉天主教以及对疟疾病例采取推荐行为。从社区卫生工作者(CHW)处获取抗疟药信息的应答者的依从性显著较低。(4) 结论:需要推广推荐药物的使用和对疟疾治疗的依从性,尤其是在农村地区,并且需要改善社区卫生工作者的参与情况。需要使宣传信息对受教育程度低的人群易于获取和理解,并且需要教会的参与。

相似文献

1
Determinants of Patients' Adherence to Malaria Treatment in the Democratic Republic of the Congo.刚果民主共和国患者对疟疾治疗依从性的决定因素
Trop Med Infect Dis. 2022 Jul 18;7(7):138. doi: 10.3390/tropicalmed7070138.
2
Knowledge of Antimalarials and Health Seeking Behaviour of Households in Case of Suspected Malaria in Democratic Republic of the Congo.刚果民主共和国疑似疟疾病例家庭的抗疟药物知识及就医行为
Trop Med Infect Dis. 2021 Aug 26;6(3):157. doi: 10.3390/tropicalmed6030157.
3
Drug use in the management of uncomplicated malaria in public health facilities in the Democratic Republic of the Congo.刚果民主共和国公立卫生机构中非复杂性疟疾管理中的药物使用情况。
Malar J. 2018 May 3;17(1):189. doi: 10.1186/s12936-018-2332-3.
4
Adherence to the referral advice after introduction of rectal artesunate for pre-referral treatment of severe malaria at the community level: a noninferiority trial in the Democratic Republic of the Congo.在社区层面引入直肠青蒿琥酯作为疟疾前转诊治疗后,对转诊建议的坚持情况:刚果民主共和国的一项非劣效性试验。
Malar J. 2019 Dec 21;18(1):438. doi: 10.1186/s12936-019-3074-6.
5
High adherence to malaria treatment: promising results of an adherence study in South Kivu, Democratic Republic of the Congo.疟疾治疗的高依从性:刚果民主共和国南基伍一项依从性研究的喜人成果。
Malar J. 2015 Oct 19;14:414. doi: 10.1186/s12936-015-0933-7.
6
Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo.注射用青蒿琥酯治疗刚果民主共和国重症疟疾的可行性与可接受性
Malar J. 2016 Jan 8;15:18. doi: 10.1186/s12936-015-1072-x.
7
In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo.青蒿琥酯-阿莫地喹和蒿甲醚-本芴醇治疗非复杂性恶性疟的体内疗效:刚果民主共和国南基伍省的一项开放随机非劣效性临床试验
Malar J. 2016 Sep 6;15(1):455. doi: 10.1186/s12936-016-1444-x.
8
Adherence to Artemisinin Combination Therapy for the treatment of uncomplicated malaria in the Democratic Republic of the Congo.在刚果民主共和国坚持使用青蒿素联合疗法治疗非复杂性疟疾。
F1000Res. 2015 Feb 24;4:51. doi: 10.12688/f1000research.6122.2. eCollection 2015.
9
An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study.刚果民主共和国医院和卫生中心中奎宁与青蒿琥酯治疗重症疟疾的操作性对比研究:MATIAS研究
Malar J. 2015 May 30;14:226. doi: 10.1186/s12936-015-0732-1.
10
Malaria policies versus practices, a reality check from Kinshasa, the capital of the Democratic Republic of Congo.疟疾政策与实践:来自刚果民主共和国首都金沙萨的现实审视
BMC Public Health. 2015 Apr 10;15:352. doi: 10.1186/s12889-015-1670-0.

引用本文的文献

1
Medication errors in malaria management in children: insights from pharmacovigilance data in the Democratic Republic of Congo.儿童疟疾治疗中的用药错误:来自刚果民主共和国药物警戒数据的见解
BMC Pharmacol Toxicol. 2025 May 22;26(1):108. doi: 10.1186/s40360-025-00941-z.
2
Community education training to optimize the use of artemisinin-based combination therapy in Kamuli District, Uganda.乌干达卡穆利区开展社区教育培训以优化青蒿素联合疗法的使用
BMC Public Health. 2024 Jul 31;24(1):2062. doi: 10.1186/s12889-024-19619-y.
3
Exploring Novel Antimalarial Compounds Targeting Enoyl-ACP Reductase: Computational and Experimental Insights.探索靶向烯酰-ACP还原酶的新型抗疟化合物:计算与实验见解
ACS Omega. 2024 May 13;9(21):22777-22793. doi: 10.1021/acsomega.3c09893. eCollection 2024 May 28.
4
Detection of Artemisinin Resistance Marker Kelch-13 469Y in Plasmodium falciparum, South Kivu, Democratic Republic of the Congo, 2022.2022 年在刚果民主共和国南基伍省检测到恶性疟原虫中的青蒿素耐药标记物 Kelch-13 469Y。
Am J Trop Med Hyg. 2024 Feb 20;110(4):653-655. doi: 10.4269/ajtmh.23-0740. Print 2024 Apr 3.
5
Community health workers in clinical research at the example of a phase IIIb/ IV antimalarial drug trial conducted in five African countries.社区卫生工作者在临床研究中的作用——以在五个非洲国家开展的 IIIb/IV 期抗疟药物试验为例。
Int J Infect Dis. 2023 Dec;137:114-117. doi: 10.1016/j.ijid.2023.10.016. Epub 2023 Oct 21.
6
Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa.处方模式和对世界卫生组织关于治疗无并发症和严重疟疾建议的遵守情况:撒哈拉以南非洲的一项前瞻性、真实世界研究。
Malar J. 2023 Jul 25;22(1):215. doi: 10.1186/s12936-023-04650-y.

本文引用的文献

1
Knowledge of Antimalarials and Health Seeking Behaviour of Households in Case of Suspected Malaria in Democratic Republic of the Congo.刚果民主共和国疑似疟疾病例家庭的抗疟药物知识及就医行为
Trop Med Infect Dis. 2021 Aug 26;6(3):157. doi: 10.3390/tropicalmed6030157.
2
Artemether-lumefantrin treatment adherence among uncomplicated plasmodium falciparum malaria patients, visiting public health facilities in AsgedeTsimbla district, Tigray, Ethiopia: a cross-sectional study.青蒿琥酯-咯萘啶治疗在埃塞俄比亚提格雷地区阿塞德齐姆布拉区公立卫生机构就诊的无并发症恶性疟原虫疟疾患者的依从性:一项横断面研究。
Antimicrob Resist Infect Control. 2020 Nov 10;9(1):184. doi: 10.1186/s13756-020-00846-y.
3
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.基于青蒿素和奎宁的治疗方案治疗妊娠合并无并发症恶性疟原虫疟疾的疗效和耐受性:系统评价和个体患者数据分析荟萃分析。
Lancet Infect Dis. 2020 Aug;20(8):943-952. doi: 10.1016/S1473-3099(20)30064-5. Epub 2020 Apr 29.
4
How delayed and non-adherent treatment contribute to onward transmission of malaria: a modelling study.延迟治疗和不坚持治疗如何导致疟疾的进一步传播:一项建模研究。
BMJ Glob Health. 2019 Dec 10;4(6):e001856. doi: 10.1136/bmjgh-2019-001856. eCollection 2019.
5
Pharmacokinetic Parameters of Quinine in Healthy Subjects and in Patients with Uncomplicated Malaria in Nigeria: Analysis of Data using a Population Approach.尼日利亚健康受试者和非复杂性疟疾患者中奎宁的药代动力学参数:采用群体方法进行数据分析
Curr Ther Res Clin Exp. 2019 Sep 12;91:33-38. doi: 10.1016/j.curtheres.2019.100567. eCollection 2019.
6
Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo.青蒿琥酯-氨酚喹啉、青蒿素-本芴醇和奎宁加克林霉素治疗刚果民主共和国金沙萨无并发症恶性疟原虫疟疾的安全性和耐受性。
PLoS One. 2019 Sep 17;14(9):e0222379. doi: 10.1371/journal.pone.0222379. eCollection 2019.
7
Salaried and voluntary community health workers: exploring how incentives and expectation gaps influence motivation.受薪和志愿社区卫生工作者:探索激励措施和期望差距如何影响动机。
Hum Resour Health. 2019 Jul 19;17(1):59. doi: 10.1186/s12960-019-0387-z.
8
Medication adherence influencing factors-an (updated) overview of systematic reviews.药物依从性影响因素——系统评价的(更新)综述。
Syst Rev. 2019 May 10;8(1):112. doi: 10.1186/s13643-019-1014-8.
9
Patients' adherence to artemisinin-based combination therapy and healthcare workers' perception and practice in Savannakhet province, Lao PDR.老挝人民民主共和国沙湾拿吉省患者对基于青蒿素的联合疗法的依从性以及医护人员的认知与实践
Trop Med Health. 2018 Dec 22;46:44. doi: 10.1186/s41182-018-0125-6. eCollection 2018.
10
Adherence to treatment with artemether-lumefantrine or amodiaquine-artesunate for uncomplicated malaria in children in Sierra Leone: a randomized trial.在塞拉利昂,儿童使用青蒿琥酯-咯萘啶或阿莫地喹-青蒿琥酯治疗无并发症疟疾的依从性:一项随机试验。
Malar J. 2018 Jun 4;17(1):222. doi: 10.1186/s12936-018-2370-x.